A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma

Trial Profile

A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Dinaciclib (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2013 Planned end date changed from 1 Jan 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
    • 17 May 2012 New source identified and integrated (SOL12063C: OHSU Knight Cancer Institute).
    • 02 Dec 2011 Planned end date changed from 1 May 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top